Emicizumab‑Kxwh Suppliers & Bulk Manufacturers

Emicizumab-kxwh is used for routine prophylaxis to prevent or reduce the frequency of bleeding episodes in patients with hemophilia A (congenital factor VIII deficiency) with or without factor VIII inhibitors. It helps restore the function of missing activated factor VIII, thereby improving blood clotting.

Emicizumab-kxwh is made from a recombinant humanized monoclonal antibody. It is produced using recombinant DNA technology in Chinese hamster ovary (CHO) cells.

The trade name of Emicizumab-kxwh is Hemlibra.

Emicizumab-kxwh is manufactured by Genentech, a member of the Roche Group.

The generic name of this product is Emicizumab-kxwh.

The brand name is Hemlibra.

Emicizumab-kxwh (Hemlibra) is manufactured by Genentech, Inc., South San Francisco, California, USA, and also produced at Roche facilities in Japan and Switzerland.